These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29516383)
1. A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis. Boiziau C; Nikolski M; Mordelet E; Aussudre J; Vargas-Sanchez K; Petry KG Inflammation; 2018 Jun; 41(3):932-947. PubMed ID: 29516383 [TBL] [Abstract][Full Text] [Related]
3. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation. Boghozian R; McKenzie BA; Saito LB; Mehta N; Branton WG; Lu J; Baker GB; Noorbakhsh F; Power C Glia; 2017 Oct; 65(10):1590-1606. PubMed ID: 28707358 [TBL] [Abstract][Full Text] [Related]
4. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Elieh-Ali-Komi D; Cao Y Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778 [TBL] [Abstract][Full Text] [Related]
5. Neuropathological Techniques to Investigate CNS Pathology in Experimental Autoimmune Encephalomyelitis (EAE). Steinbach K; Merkler D Methods Mol Biol; 2016; 1304():189-209. PubMed ID: 25146304 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963 [TBL] [Abstract][Full Text] [Related]
7. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Hammer LA; Waldner H; Zagon IS; McLaughlin PJ Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
11. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Gijbels K; Brocke S; Abrams JS; Steinman L Mol Med; 1995 Nov; 1(7):795-805. PubMed ID: 8612202 [TBL] [Abstract][Full Text] [Related]
12. C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model. Fang M; Sun Y; Hu Z; Yang J; Davies H; Wang B; Ling S; Han S Neuropharmacology; 2013 Jul; 70():83-99. PubMed ID: 23352465 [TBL] [Abstract][Full Text] [Related]
13. Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis. Hainz N; Wolf S; Tschernig T; Meier C Inflammation; 2016 Feb; 39(1):123-128. PubMed ID: 26276126 [TBL] [Abstract][Full Text] [Related]
14. Absence of system x Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920 [TBL] [Abstract][Full Text] [Related]
16. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738 [TBL] [Abstract][Full Text] [Related]
17. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration. van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787 [TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
19. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Meeson AP; Piddlesden S; Morgan BP; Reynolds R Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334 [TBL] [Abstract][Full Text] [Related]
20. Mimic peptides bonding specifically with the first and second extracellular loops of the CC chemokine receptor 5 derived from a phage display peptide library are potent inhibitors of experimental autoimmune encephalomyelitis. Zheng HM; Jiang Y; Wang JR; Gong XL; Guo BY Inflamm Res; 2011 Aug; 60(8):759-67. PubMed ID: 21533529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]